Fidelity Investments’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-8
Closed -$12 5571
2023
Q2
$12 Buy
+8
New +$12 ﹤0.01% 5259
2022
Q4
Sell
-474
Closed -$2K 5626
2022
Q3
$2K Sell
474
-257
-35% -$1.08K ﹤0.01% 4604
2022
Q2
$3K Sell
731
-10,495
-93% -$43.1K ﹤0.01% 4503
2022
Q1
$54K Buy
11,226
+11,215
+101,955% +$53.9K ﹤0.01% 3662
2021
Q4
$0 Sell
11
-3
-21% ﹤0.01% 5044
2021
Q3
$0 Hold
14
﹤0.01% 5156
2021
Q2
$0 Hold
14
﹤0.01% 4999
2021
Q1
$0 Buy
+14
New ﹤0.01% 4631
2016
Q3
Sell
-2,732
Closed -$314K 2703
2016
Q2
$314K Sell
2,732
-16,868
-86% -$1.94M ﹤0.01% 2589
2016
Q1
$2.22M Sell
19,600
-4,609
-19% -$523K ﹤0.01% 2362
2015
Q4
$4.56M Hold
24,209
﹤0.01% 2222
2015
Q3
$4.12M Hold
24,209
﹤0.01% 2228
2015
Q2
$15.3M Hold
24,209
﹤0.01% 1846
2015
Q1
$12.5M Hold
24,209
﹤0.01% 1917
2014
Q4
$13M Sell
24,209
-18,381
-43% -$9.84M ﹤0.01% 1913
2014
Q3
$63.9M Buy
42,590
+4,292
+11% +$6.44M 0.01% 1183
2014
Q2
$52.4M Sell
38,298
-2,233
-6% -$3.06M 0.01% 1320
2014
Q1
$56.3M Buy
40,531
+15,916
+65% +$22.1M 0.01% 1267
2013
Q4
$24.5M Sell
24,615
-3,922
-14% -$3.9M ﹤0.01% 1622
2013
Q3
$29.7M Sell
28,537
-88
-0.3% -$91.7K ﹤0.01% 1534
2013
Q2
$31.3M Buy
+28,625
New +$31.3M 0.01% 1463